A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment

Karatayli, Ersin; Karayalcin, Selim; Karaaslan, Hayri; KAYHAN, HANDAN; Turkyilmaz, A.; Sahin, Fikret; Yurdaydin, Cihan; Bozdayi, A.

A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment

Atıf İçin Kopyala

Karatayli E., Karayalcin S., Karaaslan H., KAYHAN H., Turkyilmaz A. R., Sahin F., ...Daha Fazla

ANTIVIRAL THERAPY, cilt.12, sa.5, ss.761-768, 2007 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12 Sayı: 5
Basım Tarihi: 2007
Dergi Adı: ANTIVIRAL THERAPY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.761-768
Gazi Üniversitesi Adresli: Hayır

Özet

Aims: This study was conducted to clarify the resistance profile of a novel mutation pattern emerging during lamivudine (3TC) therapy and showing cross-resistance to adefovir dipivoxil (ADV) in a patient with chronic hepatitis B.